Cellestia Biotech
Latest round
- Series B
Last raised
- Dec 2019
Total raised
- $46M
Investors
- 4
About Cellestia Biotech
Founded in 2014, Cellestia Biotech AG is based in Basel, Switzerland. The company specializes in creating therapeutic solutions targeting drug-resistant conditions. Raj Lehal, the founder and CEO, has previously founded other companies.000 mn.Cellestia Biotech AG specializes in the development of innovative therapeutic solutions targeting autoimmune diseases and multi-drug resistant cancers. Their core product offerings include CB-103, a pioneering transcriptional Notch inhibitor, which is currently undergoing clinical trials for conditions like breast cancer and hematological malignancies.Cellestia Biotech AG's revenue model is based on strategic partnerships within the biopharmaceutical industry, engaging in collaborative agreements with research institutions, pharmaceutical companies, and clinical trial networks. Revenue is generated through milestone payments and royalties upon successful commercialization of therapies, particularly for flagship products like CB-103. The company is actively designing upcoming therapies that will target previously undrugged conditions. Additionally, Cellestia aims to expand its market reach into new geographic regions, focusing on European and North American markets by 2023.
Who invested in Cellestia Biotech
4 investors across 3 rounds
See all investors in Cellestia Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cellestia Biotech
Who invested in Cellestia Biotech?
Cellestia Biotech has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellestia Biotech raised?
Cellestia Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cellestia Biotech last raise money?
Cellestia Biotech's most recent round on record is a Series B, in Dec 2019.
What does Cellestia Biotech do?
Founded in 2014, Cellestia Biotech AG is based in Basel, Switzerland.
Where is Cellestia Biotech headquartered?
Cellestia Biotech is headquartered in Basel, Switzerland.
Which VCs invest in companies like Cellestia Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Cellestia Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Cellestia Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.